Applied Finance Capital Management, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1966007
SAN JUAN, PR
Position in BMY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,071,439
-$265,026 QoQ
Shares Held
35,950
-6.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#824
of 2,506 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Applied Finance Capital Management, LLC holds $53,647,387 across 10 Drug Manufacturers - General names. BMY ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
133,454 | $17,148,839 | |
| 2 | LLY |
ELI LILLY & Co
|
12,549 | $15,051,648 | |
| 3 | JNJ |
Johnson & Johnson
|
25,604 | $6,502,647 | |
| 4 | ABBV |
AbbVie Inc.
|
25,128 | $6,323,209 | |
| 5 | AMGN |
Amgen Inc
|
6,845 | $2,478,711 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
35,950 | $2,071,439 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
14,693 | $1,856,313 | |
| 8 | NVS |
Novartis AG
|
6,260 | $981,067 |
All Filings in BMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,071,439 | 35,950 | Shares | Sole | 2026-07-28 | |
| 2025-03-31 | $2,336,465 | 38,309 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,098,149 | 37,096 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,098,160 | 40,552 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,403,547 | 33,796 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||